Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans lowered its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 57.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 946,506 shares of the real estate investment trust’s stock after selling 1,276,823 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.39% of Sabra Healthcare REIT worth $17,454,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in SBRA. Engineers Gate Manager LP increased its position in shares of Sabra Healthcare REIT by 3,190.3% during the second quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock worth $58,626,000 after purchasing an additional 3,082,677 shares in the last quarter. Norges Bank acquired a new stake in Sabra Healthcare REIT during the 2nd quarter worth $54,385,000. Balyasny Asset Management L.P. purchased a new stake in shares of Sabra Healthcare REIT during the second quarter worth $49,955,000. Bank of Montreal Can grew its holdings in shares of Sabra Healthcare REIT by 244.1% during the second quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust’s stock worth $47,501,000 after buying an additional 1,827,361 shares in the last quarter. Finally, Qube Research & Technologies Ltd raised its position in shares of Sabra Healthcare REIT by 856.5% in the second quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock valued at $25,797,000 after buying an additional 1,252,708 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Stock Down 1.8%

Shares of NASDAQ SBRA opened at $18.85 on Wednesday. The company has a market capitalization of $4.70 billion, a P/E ratio of 26.18, a P/E/G ratio of 1.22 and a beta of 0.67. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19. The company has a 50 day simple moving average of $18.54 and a 200-day simple moving average of $18.53. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.01. The company had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 166.67%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a report on Monday. Cantor Fitzgerald assumed coverage on Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. BMO Capital Markets increased their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a report on Monday, August 25th. National Bankshares set a $22.00 price objective on Sabra Healthcare REIT in a research report on Friday, October 17th. Finally, Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.